Filtered By:
Condition: Eczema
This page shows you your search results in order of date. This is page number 15.
Order by Relevance | Date
Total 2491 results found since Jan 2013.
Atopic Dermatitis Polypharmacy and Out-Of-Pocket Healthcare Expenses
CONCLUSION: Individuals with AD report considerable polypharmacy, which is associated with increased OOP expenses and harmful financial impact. Strategies are needed to reduce polypharmacy, minimize OOP costs, and optimize clinical outcomes. J Drugs Dermatol. 2023;22(2): doi:10.36849/JDD.7038.PMID:36745366 | DOI:10.36849/JDD.7038
Source: Journal of Drugs in Dermatology - February 6, 2023 Category: Dermatology Authors: Raj Chovatiya Wendy Smith Begolka Isabelle Thibau Jonathan Silverberg Source Type: research
